awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49959323-47690237-8D94-419D-9407-6B3175A05D92
Q49959323-47690237-8D94-419D-9407-6B3175A05D92
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49959323-47690237-8D94-419D-9407-6B3175A05D92
Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer.
P2860
Q49959323-47690237-8D94-419D-9407-6B3175A05D92
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49959323-47690237-8D94-419D-9407-6B3175A05D92
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5890b7fdaf1a60dcb1690547ccc380a9f2f6eb6c
P2860
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.